What Солодки сироп Treats: Main Uses and Benefits

The traditional therapeutic application of the active ingredient is commonly used to help with expectorant support in cough associated with cold. This preparation is relevant when respiratory symptoms include a wet, productive cough associated with the accumulation of thick, tenacious mucus or phlegm in the chest. The role of this preparation is relevant for easing symptoms that may interfere with daily comfort during conditions involving inflammatory or irritative states in the lower respiratory tract.

Солодки сироп is applied as an adjunctive component in the complex therapy for conditions characterized by periods of heightened symptoms such as acute and chronic bronchitis and similar inflammatory respiratory illnesses. Its role is generally to provide supportive relief and assists with managing the impact of symptoms that interfere with daily functioning during periods of seasonal illness. By assisting the process of loosening thick secretions, it provides support that helps ease the overall symptom burden and contributes to improved comfort during symptomatic periods.

“The preparation is used for managing cough and congestion when tenacious mucus is present, supporting the natural process of mucus clearance.”

---

Quick Fact: Relief for Viscous Secretion Accumulation and Wet Cough Symptoms

---

Regulatory References

1. European Union herbal monograph

Eligibility and Contraindications

The eligibility for using Солодки сироп (Licorice Syrup) is strictly defined by regulatory warnings concerning its active component, Glycyrrhizae radix.

Populations for Whom Use is Prohibited or Restricted

Official government documents list several absolute contraindications and populations for whom use is not recommended:

• Hypersensitivity: Contraindicated in patients with a known allergy to the active substance, Glycyrrhizae radix, or any excipients.
• Reproductive Status: Not recommended during pregnancy or lactation as safety has not been established and regulatory bodies cite concerns regarding the developing fetus/infant.
• Age Restrictions: Use is not recommended in children and adolescents under 18 years of age due to a lack of established safety and efficacy data in this age group.

Condition-Specific Non-Eligibility

Use is highly restricted or contraindicated in patients with specific pre-existing health conditions, as they are more susceptible to adverse effects like fluid retention and electrolyte imbalance:

• Cardiovascular/Renal: Individuals with hypertension (high blood pressure), hypokalemia (low potassium levels), kidney diseases, or congestive heart failure must avoid use.
• Hepatic: Patients with liver disorders, such as cirrhosis or cholestatic liver diseases, are generally restricted from use.
• Other Restrictions: Patients taking other licorice-containing products should not use this medicine concurrently, as this increases the risk of serious adverse events.

Interactions with other medicines and products

The official interaction profile for Солодки сироп is primarily defined by the impact of its active component, Glycyrrhizin, on electrolyte balance and drug clearance.

Pharmacodynamic Interference and Electrolyte Risk

Co-administration with Diuretics (thiazide or loop types) carries a risk of additive hypokalemic effects, potentially causing a severe reduction in plasma potassium concentration. This hypokalemia increases the risk of toxicity with Cardiac Glycosides (e.g., Digoxin), heightening the danger of serious cardiac events. Due to potential fluid and sodium retention, the medicine may also officially reduce the efficacy of Antihypertensive Agents. Furthermore, the therapeutic effect of the anticoagulant Warfarin may be reduced.

Systemic Exposure Modification

The profile includes pharmacokinetic interactions that modify drug levels. Co-administration with Corticosteroids is associated with an increase in their plasma concentration due to documented enzyme inhibition. The active metabolite is also recognized as an inhibitor of the P-glycoprotein (P-gp) transporter, a mechanism which may increase the systemic exposure of co-administered P-gp substrate medicines. Regulatory documents specify that these interaction risks are more clinically significant in populations with pre-existing heart disease or hypertension.

The mechanism of action for Солодки сироп is primarily mediated by its main constituent, glycyrrhizin (glycyrrhizic acid), and its major active metabolite, 18beta-glycyrrhetinic acid (enoxolone), formed by intestinal bacterial hydrolysis.

Molecular and Intracellular Pathways

The active metabolite, 18beta-glycyrrhetinic acid, is a non-selective inhibitor of the enzyme 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2). This enzyme is critical for converting the active glucocorticoid cortisol into its inactive metabolite, cortisone, particularly in the kidneys. Inhibition of 11beta-HSD2 decreases the metabolic inactivation of cortisol in mineralocorticoid receptor-expressing cells.

Downstream Cascades and System-Level Consequences

The resulting local increase in active cortisol concentration leads to its subsequent binding and activation of the non-selective mineralocorticoid receptor (MR) in the kidney. MR activation initiates a signaling cascade that modulates the expression of genes involved in electrolyte transport, specifically increasing sodium reabsorption and potassium excretion in the distal tubules and collecting ducts. This results in system-level physiological modulation characterized by increased fluid retention and altered serum electrolyte balance.

Official Administration Guidelines

Солодки сироп (Licorice Syrup) is administered strictly via the oral route as a standardized liquid solution. Its official usage is defined by specific dose, frequency, and time constraints that adhere to official labeling.

Dosage and Schedule

The standard single dose prescribed for adults and adolescents over 12 years of age is 1 tablespoon, which corresponds to approximately 15 mL. This measured dose is to be taken 3 to 4 times per day, establishing a maximum daily administration frequency.

For optimal adherence to the protocol, the administration of the syrup is instructed to occur after meals. The medicine is a ready-to-use solution and typically does not require dilution before consumption.

---

Duration and Age Restrictions

Administration is intended for short-term use only. Continuous administration should not exceed a maximum duration of four consecutive weeks without further professional guidance.

Regarding pediatric use, the preparation is not recommended or authorized for use in children under 12 years of age. Furthermore, the formulation contains ethanol (at least 5 vol. %) and sugars, which are practical constraints defined by the official composition.

These instructions define a structured usage protocol that governs the safe and appropriate administration of the product as outlined in the product specifications.

Research Evidence: Overview of Studies for Солодки сироп

Evidence for Use in Expectorant Support and Mucus Buildup

Evidence for the active ingredient in Солодки сироп, licorice root extract, comes from official regulatory Assessment Reports, relying primarily on a history of documented Traditional Use, alongside newer, focused Randomized Controlled Trials (RCTs). These studies evaluated short-term symptom patterns associated with conditions involving heightened symptoms, such as acute bronchitis or the common cold. Research highlights changes measured during the study period in patient-reported cough scores.

Clinical Trial Outcomes and Study Design

Clinical evidence was primarily evaluated in cohorts of Adults and the elderly. Researchers monitored patient-reported outcomes, such as cough severity and related quality of life instruments. Some clinical data reviewed was associated with the extract being part of a combination product, which limits the ability to isolate its specific action as a monotherapy. The results apply only to the populations studied, and research does not determine whether an individual will respond similarly.

Evidence in Special Populations

The majority of clinical research was observed in adult populations, including specific trials that examined adults dealing with chronic cough. However, evidence is limited for use in certain groups, such as children and adolescents, resulting in insufficient clinical data being available for these populations. The available information primarily addresses the specific adult cohorts and acute symptoms under which the studies were conducted.

Evidence Gaps and Remaining Uncertainties

The quality of the evidence varies across studies. The official status for expectorant support is based on extensive documentation of Traditional Use rather than being established exclusively through large-scale RCTs. The follow-up durations were limited across the board, meaning long-term effects are not fully established and comparative evidence is lacking for the licorice extract as a single-ingredient therapy.

Key Studies & References

1. The effectiveness of a traditional Persian medicine preparation in the treatment of chronic cough: A randomized, double-blinded, placebo-controlled clinical trial

Common questions about Солодки сироп (FAQ)

Q: Can Солодки сироп be used for a dry cough?

A: Official indications for this syrup typically describe its purpose as an expectorant, which supports the clearance of phlegm and mucus in the respiratory tract. This action, described as assisting in the discharge of phlegm and mucus, is associated with the relief of a wet or productive cough. Use specifically for a dry cough is not generally included in the product's official stated therapeutic purpose.

Q: Why does the syrup sometimes look cloudy or change color?

A: According to official storage information, the formation of a precipitate (solid particles settling at the bottom) is a permissible change during storage, and this can make the syrup appear cloudy. Since this is a plant-derived product, some slight natural color variation may also be observed, but its integrity is generally maintained when stored according to official instructions.

Q: Can Солодки сироп be taken at night?

A: Official dosing instructions specify that the syrup is taken multiple times per day, but regulatory documents do not specifically list any restrictions against nighttime use. Furthermore, the medicine is not officially described as having a known sedative effect.

Q: Is there a difference between 'Licorice root syrup' and Солодки сироп?

A: Солодки сироп translates directly to 'Licorice Syrup.' The official active ingredient is the extract of Glycyrrhizae Radix, which is Licorice Root. This confirms that these terms generally refer to the same type of standardized herbal medicinal product preparation.

Q: Are there any known issues with taking Солодки сироп and herbal teas?

A: The official drug interaction profile primarily focuses on conflicts with prescription medicines that affect electrolyte balance, such as diuretics. However, regulatory warnings often mention avoiding the concurrent use of other products that contain licorice, including certain herbal teas, to reduce the risk of exceeding safe intake levels of the active ingredient.

Q: Does Солодки сироп interact with birth control pills?

A: The official drug interaction documents primarily list interactions with drug classes like diuretics, cardiac glycosides, and corticosteroids. A specific interaction or contraindication with combined oral contraceptives is not typically cited in the main regulatory profile for this preparation.

Q: Is Солодки сироп gluten-free?

A: Gluten is not typically listed as a core excipient in the official composition of this herbal syrup. Excipient information is available in the regulatory labeling. The absence of common gluten-containing ingredients is noted in the official composition.

Q: Do any official sources or studies mention Солодки сироп's use in combination with antibiotics?

A: Official interaction documents do not generally list antibiotics as a class that interacts with the product's primary mechanism. The official research summaries also focus on the syrup's use as an expectorant, not on combination therapy with antibiotics.

Q: Is it normal to feel a change in taste after using Солодки сироп?

A: The syrup contains a saccharide base, giving it a sweet taste. While regulatory side effect lists primarily document medically significant events, mild digestive tract disturbances have been reported, which may sometimes be linked to subjective taste changes.

Q: Does Солодки сироп have a known sedative effect?

A: The official documentation does not list sedation as a known adverse reaction or pharmacological property of the syrup.

Q: Can Солодки сироп be used alongside pain relievers?

A: The official interaction profile focuses on medicines that significantly affect potassium levels, fluid balance, or blood pressure. Interactions with common over-the-counter pain relievers, such as acetaminophen or ibuprofen, are not typically cited as being restricted in the main regulatory documents.

Q: Does Солодки сироп contain alcohol?

A: Yes, the official composition of the product states that the formulation contains ethanol (alcohol). This is noted as a constraint in the regulatory labeling.

Q: What ingredients in Солодки сироп, besides the active one, should users be aware of?

A: Users should be aware of the key excipients listed in the regulatory documents, which include ethanol (alcohol) and a saccharide base (sugars). These components define the practical constraints of the syrup formulation.

Q: What are the common reasons someone might stop using Солодки сироп?

A: Official regulatory documents define reasons for discontinuation, which include reaching the maximum advised treatment duration, which is typically four consecutive weeks. Discontinuation is generally indicated if a person experiences documented side effects, such as signs of hypertension or low potassium levels (hypokalemia).

Q: What does 'expectorant' mean in the context of Солодки сироп?

A: The classification as an expectorant means the preparation is primarily designed to support the body’s natural mechanisms for respiratory tract clearance. Its function is to help facilitate the discharge of accumulated phlegm and mucus from the airways.

Q: What are the general guidelines regarding Солодки сироп and driving or operating machinery?

A: Official documentation often includes a recommendation to observe caution when performing potentially hazardous activities, such as driving or operating machinery. This guidance is provided due to the presence of ethanol (alcohol) in the formulation.

Q: Are there different strengths or concentrations of Солодки сироп?

A: The official documentation describes a standardized liquid preparation in the form of a syrup. Regulatory documents primarily focus on the approved formulation, which is standardized to ensure consistent use.

Q: What is the general consensus on Солодки сироп's use for persistent coughs?

A: While some clinical research has examined adult cohorts dealing with chronic cough, the product is officially designated for short-term use only. Administration is generally advised not to exceed four consecutive weeks, which restricts its use for persistent or long-term conditions.

Q: Are there any known interactions between Солодки сироп and common vitamins or supplements?

A: The official interaction profile is limited to prescription and non-prescription medicines with documented conflicts related to blood pressure or electrolyte effects. Interactions with common vitamins or supplements are not typically addressed in the main regulatory documents.

Q: Is there a risk of dependency or habit-forming effects with Солодки сироп?

A: Regulatory safety documents for this preparation do not typically list dependency, abuse potential, or habit-forming effects as a known risk associated with its use.

How to Store and Dispose of Солодки сироп

Storage and disposal must align strictly with regulatory labeling to preserve the syrup's stability.

Official Storage Conditions

Requirement	Specific Condition
Temperature	Not above 25 C (some labels specify 15 C to 25 C).
Protection	Must be stored in a place protected from light.
Child Safety	Mandatory to keep out of reach of children.
Observation	The formation of a precipitate is permissible during storage.

Stability and Disposal

The maximum shelf life for an unopened bottle is 2 years. However, once the container is opened, the syrup's stability is reduced, and it must be used within a period not exceeding six months. The regulatory instruction for disposal requires the product to be disposed of when expired. No specific environmental or household waste restrictions are universally mandated in the official labeling.